This is the authors' abstract. We don't add key points for this paper.
Background: Ewing’s sarcoma (EWS)/peripheral primitive neuroectodermal tumor (pPNET) is a rare, aggressive small‑round‑cell malignancy primarily of children and adolescents; congenital presentations are exceptional. We report a neonate with congenital pPNET of the arm. Case presentation: A 24‑day‑old full‑term female presented with a progressively enlarging left‑arm swelling present since birth. Birth and maternal histories were unremarkable; no family history of genetic disease. Clinical findings: Examination revealed a 6 × 6 cm soft, immobile posterolateral arm mass. Laboratory values were within normal limits. Diagnostic assessment: Ultrasound showed a hypoechoic lobulated intermuscular lesion. MRI demonstrated a well‑circumscribed T1 hypointense, T2/STIR hyperintense ovoid mass abutting but not invading adjacent structures. FNAC revealed sheets of small round blue cells. Excisional biopsy showed uniform small round cells; immunohistochemistry was CD99 and vimentin positive, desmin, myogenin, synaptophysin, S‑100, EMA, and LCA negative. Cytogenetic/molecular testing was not performed due to resource constraints. Therapeutic intervention: Radical surgical resection followed by four cycles of cisplatin and cyclophosphamide at 3‑week intervals. Follow‑up and outcomes: Immediate postoperative imaging showed no metastasis; postoperative course was uneventful. Patient lost to follow‑up after three months. Conclusion: Congenital pPNET/EWS is extremely rare and aggressive. Diagnosis relies on histopathology and IHC when molecular tests are unavailable. Early recognition and multimodal therapy are critical, but prognosis in neonates remains guarded.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: